153 related articles for article (PubMed ID: 23418107)
1. Steady-state equilibrium phase inversion recovery ON-resonant water suppression (IRON) MR angiography in conjunction with superparamagnetic nanoparticles. A robust technique for imaging within a wide range of contrast agent dosages.
Gitsioudis G; Stuber M; Arend I; Thomas M; Yu J; Hilbel T; Giannitsis E; Katus HA; Korosoglou G
J Magn Reson Imaging; 2013 Oct; 38(4):836-44. PubMed ID: 23418107
[TBL] [Abstract][Full Text] [Related]
2. Off-resonance magnetic resonance angiography improves visualization of in-stent lumen in peripheral nitinol stents compared to conventional T1-weighted acquisitions: an in vitro comparison study.
Gitsioudis G; Fortner P; Stuber M; Missiou A; Andre F; Müller OJ; Katus HA; Korosoglou G
Int J Cardiovasc Imaging; 2016 Nov; 32(11):1645-1655. PubMed ID: 27535040
[TBL] [Abstract][Full Text] [Related]
3. Off-resonance angiography: a new method to depict vessels--phantom and rabbit studies.
Korosoglou G; Shah S; Vonken EJ; Gilson WD; Schär M; Tang L; Kraitchman DL; Boston RC; Sosnovik DE; Weiss RG; Weissleder R; Stuber M
Radiology; 2008 Nov; 249(2):501-9. PubMed ID: 18780823
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced magnetic resonance angiography in rabbits: evaluation of the gadolinium-based agent p846 and the iron-based blood pool agent p904 in comparison with gadoterate meglumine.
Kinner S; Maderwald S; Parohl N; Albert J; Corot C; Robert P; Barkhausen J; Vogt FM
Invest Radiol; 2011 Aug; 46(8):524-9. PubMed ID: 21577130
[TBL] [Abstract][Full Text] [Related]
5. New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits.
Taupitz M; Schnorr J; Abramjuk C; Wagner S; Pilgrimm H; Hünigen H; Hamm B
J Magn Reson Imaging; 2000 Dec; 12(6):905-11. PubMed ID: 11105029
[TBL] [Abstract][Full Text] [Related]
6. First-pass and equilibrium-MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot study.
Tombach B; Reimer P; Bremer C; Allkemper T; Engelhardt M; Mahler M; Ebert W; Heindel W
NMR Biomed; 2004 Nov; 17(7):500-6. PubMed ID: 15523717
[TBL] [Abstract][Full Text] [Related]
7. Positive contrast MR-lymphography using inversion recovery with ON-resonant water suppression (IRON).
Korosoglou G; Tang L; Kedziorek D; Cosby K; Gilson WD; Vonken EJ; Schär M; Sosnovik D; Kraitchman DL; Weiss RG; Weissleder R; Stuber M
J Magn Reson Imaging; 2008 May; 27(5):1175-80. PubMed ID: 18425827
[TBL] [Abstract][Full Text] [Related]
8. Reducing Contrast Agent Dose in Cardiovascular MR Angiography with Deep Learning.
Montalt-Tordera J; Quail M; Steeden JA; Muthurangu V
J Magn Reson Imaging; 2021 Sep; 54(3):795-805. PubMed ID: 33619859
[TBL] [Abstract][Full Text] [Related]
9. Coronary MR angiography at 3T: fat suppression versus water-fat separation.
Nezafat M; Henningsson M; Ripley DP; Dedieu N; Greil G; Greenwood JP; Börnert P; Plein S; Botnar RM
MAGMA; 2016 Oct; 29(5):733-8. PubMed ID: 27038934
[TBL] [Abstract][Full Text] [Related]
10. RES-specific imaging of the liver and spleen with iron oxide particles designed for blood pool MR-angiography.
Bremer C; Allkemper T; Baermig J; Reimer P
J Magn Reson Imaging; 1999 Sep; 10(3):461-7. PubMed ID: 10508309
[TBL] [Abstract][Full Text] [Related]
11. Effect of field strengths on magnetic resonance angiography: comparison of an ultrasmall superparamagnetic iron oxide blood-pool contrast agent and gadopentetate dimeglumine in rabbits at 1.5 and 3.0 tesla.
Allkemper T; Heindel W; Kooijman H; Ebert W; Tombach B
Invest Radiol; 2006 Feb; 41(2):97-104. PubMed ID: 16428979
[TBL] [Abstract][Full Text] [Related]
12. Optimization of ultrasmall superparamagnetic iron oxide (P904)-enhanced magnetic resonance imaging of lymph nodes: initial experience in a mouse model.
Yoo RE; Cho HR; Choi SH; Won JK; Kim JH; Sohn CH
Anticancer Res; 2014 Oct; 34(10):5389-96. PubMed ID: 25275033
[TBL] [Abstract][Full Text] [Related]
13. Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model.
Sigovan M; Boussel L; Sulaiman A; Sappey-Marinier D; Alsaid H; Desbleds-Mansard C; Ibarrola D; Gamondès D; Corot C; Lancelot E; Raynaud JS; Vives V; Laclédère C; Violas X; Douek PC; Canet-Soulas E
Radiology; 2009 Aug; 252(2):401-9. PubMed ID: 19703881
[TBL] [Abstract][Full Text] [Related]
14. Dixon-based fat-free MR-angiography compared to first pass and steady-state high-resolution MR-angiography using a blood pool contrast agent.
Homsi R; Gieseke J; Kukuk GM; Träber F; Willinek WA; Schild HH; Hadizadeh DR
Magn Reson Imaging; 2015 Nov; 33(9):1035-1042. PubMed ID: 26220860
[TBL] [Abstract][Full Text] [Related]
15. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
[TBL] [Abstract][Full Text] [Related]
16. Extremely Small Pseudoparamagnetic Iron Oxide Nanoparticle as a Novel Blood Pool T1 Magnetic Resonance Contrast Agent for 3 T Whole-Heart Coronary Angiography in Canines: Comparison With Gadoterate Meglumine.
Park EA; Lee W; So YH; Lee YS; Jeon BS; Choi KS; Kim EG; Myeong WJ
Invest Radiol; 2017 Feb; 52(2):128-133. PubMed ID: 27977466
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Sigovan M; Kaye E; Lancelot E; Corot C; Provost N; Majd Z; Breisse M; Canet-Soulas E
Invest Radiol; 2012 Sep; 47(9):546-52. PubMed ID: 22864378
[TBL] [Abstract][Full Text] [Related]
18. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
[TBL] [Abstract][Full Text] [Related]
19. Evaluating size-dependent relaxivity of PEGylated-USPIOs to develop gadolinium-free T1 contrast agents for vascular imaging.
Khandhar AP; Wilson GJ; Kaul MG; Salamon J; Jung C; Krishnan KM
J Biomed Mater Res A; 2018 Sep; 106(9):2440-2447. PubMed ID: 29664208
[TBL] [Abstract][Full Text] [Related]
20. Ultrasmall superparamagnetic iron oxide to enhance MRA of the renal and coronary arteries: studies in human patients.
Stillman AE; Wilke N; Li D; Haacke M; McLachlan S
J Comput Assist Tomogr; 1996; 20(1):51-5. PubMed ID: 8576482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
